Erste Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Erste Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18,000	Closed	-$102K	–	539
2024 Q3	$102K	Hold	18,000	–	–	﹤0.01%	495
2024 Q2	$77.2K	Hold	18,000	–	–	﹤0.01%	498
2024 Q1	$91.1K	Hold	18,000	–	–	﹤0.01%	493
2023 Q4	$173K	Hold	18,000	–	–	﹤0.01%	486
2023 Q3	$121K	Hold	18,000	–	–	﹤0.01%	496
2023 Q2	$142K	Hold	18,000	–	–	﹤0.01%	507
2023 Q1	$150K	Hold	18,000	–	–	﹤0.01%	514
2022 Q4	$164K	Hold	18,000	–	–	﹤0.01%	512
2022 Q3	$176K	Hold	18,000	–	–	﹤0.01%	504
2022 Q2	$178K	Hold	18,000	–	–	﹤0.01%	517
2022 Q1	$221K	Buy	+18,000	New	+$221K	﹤0.01%	500

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Erste Asset Management's AVXL Position: Q4 2024 in Review

Erste Asset Management sold out of Anavex Life Sciences (AVXL) in Q4 2024, closing a stake of 18,000 shares — an estimated $102K sold.

Erste Asset Management first reported a position in AVXL in Q1 2022 and held it in 11 quarters. The position peaked at $221K in Q1 2022. 168 funds tracked by Wall St. Rank hold AVXL as of Q4 2024.

Erste Asset Management reported no remaining Anavex Life Sciences position as of Q4 2024 after selling out during the quarter.
Erste Asset Management sold 18,000 Anavex Life Sciences shares in Q4 2024, an estimated $102K.
Erste Asset Management first reported a position in Anavex Life Sciences in Q1 2022 and held it in 11 quarters.
Erste Asset Management's Anavex Life Sciences position peaked at $221K in Q1 2022.
168 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2024.

Based on Erste Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.